An AI-driven platform connecting cancer patients to bio-pharmaceutical clinical trials.
Targeted cancer therapies • Cancer genomics • Tumor profiling technologies • Clinical trial selection • Second Opinion
51 - 200
💰 $16.5M Series B on 2022-12
August 29
🏡 Remote – Anywhere in California
⏰ Full Time
🟢 Junior
⚙️ Operations
August 27
🟡 Mid-level
🟠 Senior
March 5
February 27
🔴 Lead
January 17
📋 Program Manager
August 15, 2023
💰 Business Development (BDR)